Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Q1-2023 Durable Medical Equipment (DME) Update

Skip to the end of the Expertise Menu

Q1-2023 Durable Medical Equipment (DME) Update

After a slowdown of M&A activity in late 2022 that limited consolidation activity to a few strategic buyers and saw an earnings miss from AdaptHealth, Q1 2023 saw an uptick in new platform creation as additional private equity firms target investments across DME. Most notably, MasVida was recapitalized by Brixey & Meyer Capital (detailed below) to create a new platform.

Several DME product categories stand to benefit from recent Medicare reimbursement and eligibility changes, which contribute to an improving outlook for 2023. Continuous glucose monitors (CGM) are expected to remain a high-growth product as Medicare increased reimbursement and broadened eligibility criteria. Complex rehab providers also stand to benefit from Medicare coverage for power seat elevation systems.

To print and download the full DME¬†Update report, please click below…

[holo_button icon=”/wp-content/uploads/2023/04/Q1-2023-DME-Newsletter.pdf” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]